| Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia A Sanjuan-Pla, C Bueno, C Prieto, P Acha, RW Stam, R Marschalek, ... Blood, The Journal of the American Society of Hematology 126 (25), 2676-2685, 2015 | 130 | 2015 |
| Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms L Palomo, M Meggendorfer, S Hutter, S Twardziok, V Ademà, I Fuhrmann, ... Blood, The Journal of the American Society of Hematology 136 (16), 1851-1862, 2020 | 128 | 2020 |
| Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia L Palomo, M Ibanez, M Abáigar, I Vazquez, S Alvarez, M Cabezon, ... British Journal of Haematology 188 (5), 605-622, 2020 | 44 | 2020 |
| Diagnostic and prognostic contribution of targeted NGS in patients with triple-negative myeloproliferative neoplasms P Acha, M Xandri, F Fuster-Tormo, L Palomo, B Xicoy, M Cabezón, ... Am J Hematol 94 (10), E264-E267, 2019 | 23 | 2019 |
| Targeted deep sequencing of CD34+ cells from peripheral blood can reproduce bone marrow molecular profile in myelodysplastic syndromes R Martin, P Acha, C Ganster, L Palomo, S Dierks, F Fuster‐Tormo, ... American journal of hematology 93 (6), E152-E154, 2018 | 18 | 2018 |
| Genetic aspects of myelodysplastic/myeloproliferative neoplasms L Palomo, P Acha, F Solé Cancers 13 (9), 2120, 2021 | 15 | 2021 |
| Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed Sideroblasts V Adema, F Ma, R Kanagal-Shamanna, N Thongon, G Montalban-Bravo, ... Blood cancer discovery 3 (6), 554-567, 2022 | 8 | 2022 |
| Analysis of intratumoral heterogeneity in myelodysplastic syndromes with isolated del (5q) using a single cell approach P Acha, L Palomo, F Fuster-Tormo, B Xicoy, M Mallo, A Manzanares, ... Cancers 13 (4), 841, 2021 | 8 | 2021 |
| Myelodysplastic Syndromes with Isolated del (5q): Value of Molecular Alterations for Diagnostic and Prognostic Assessment P Acha, M Mallo, F Solé Cancers 14 (22), 5531, 2022 | 3 | 2022 |
| TP53 gene allelic state in myelodysplastic syndromes (MDS) with isolated 5q deletion J Montoro, L Palomo, C Haferlach, P Acha, O Chan, VN Garces, Y Kubota, ... Blood 142, 1001, 2023 | 1 | 2023 |
| Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy I Campillo-Marcos, M Casado-Pelaez, V Davalos, G Ferrer, C Mata, ... Cancer Research Communications 4 (2), 365-377, 2024 | | 2024 |
| Two-Time Multiplexed Targeted Next-Generation Sequencing Might Help the Implementation of Germline Screening Tools for Myelodysplastic Syndromes/Hematologic Neoplasms O Calvete, J Mestre, RM Risueño, A Manzanares, P Acha, B Xicoy, F Solé Biomedicines 11 (12), 3222, 2023 | | 2023 |
| Role and Prevalence of Risk Factors That Trigger Therapy Related Myeloid Neoplasms (TRMN) in Patients with Previous Treated Breast Cancer O Calvete, R Kanagal-Shamanna, J Mestre, G Montalban-Bravo, ... Blood 142, 4593, 2023 | | 2023 |
| Clinical and Molecular Characterization of Patients with Therapy Related Myeloid Neoplasms (TRMN) O Calvete, J Mestre, G Montalban-Bravo, K Sasaki, CD DiNardo, ... Blood 142, 3224, 2023 | | 2023 |
| Clonal Hematopoiesis of Indeterminate Potential (CHIP) Related to the Etiology of Ischemic Stroke CP Jou, JMC Zarraquiños, L Palomo, CL Hernández, MAR del Fueyo, ... Blood 142, 5601, 2023 | | 2023 |
| Usefulness of Peripheral Blood Samples in Diagnosis and Prognosis Assessment of Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia Low Risk Patients Using Next … P Acha, A Manzanares, B Xicoy, L Zamora, C de la Fuente, M Julià, ... Blood 142, 6477, 2023 | | 2023 |
| The Transcriptional Impact of 5q Deletion in MDS at Single Cell Resolution A Diaz-Mazkiaran, G Serrano, N Berastegui, P Garcia-Olloqui, S Huerga, ... Blood 142 (Supplement 1), 1850-1850, 2023 | | 2023 |
| P695: SINGLE-CELL MULTIOMICS ANALYSIS OF MYELODYSPLASTIC SYNDROME PREDICTS CLINICAL RESPONSE TO TREATMENT WITH DNA DEMETHYLATION AGENT I Campillo-Marcos, M Casado-Pelaez, V Davalos, G Ferrer, C Mata, ... HemaSphere 7 (S3), e4630768, 2023 | | 2023 |
| CHARACTERIZATION OF TRANSCRIPTIONAL ALTERATIONS LEADING TO ABERRANT MYELOID DIFFERENTIATION IN MYELODYSPLASTIC SYNDROMES A Diaz-Mazkiaran, J De La Fuente, G Serrano, M Ainciburu, ... Leukemia Research 128, 107123, 2023 | | 2023 |
| Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations: TP53 ALLELIC STATE DID NOT INFLUENCE THE PROGNOSIS IN MYELODYSPLASTIC SYNDROMES (MDS) WITH 5Q DELETION MJ Montoro, L Palomo, C Haferlach, F Fuster-Tormo, M Meggendorfer, ... Leukemia Research 128, 107187, 2023 | | 2023 |
